Biogen (BIIB) Short term Debt (2012 - 2026)

Biogen has reported Short term Debt for 13 years, with the latest figure at $800.0 million in Q2 2026.

• On a quarterly basis, Short term Debt rose 433.33% year-over-year to $800.0 million in Q2 2026; TTM through Jun 2026 was $800.0 million, a 433.33% increase from a year earlier, with the FY2024 full-year figure at $1.7 billion, up 1065.73% from the prior year.
• Short term Debt was $800.0 million for Q2 2026 at Biogen, up from $150.0 million in the prior quarter.
• The five-year high for Short term Debt was $1.7 billion in Q4 2024, with the low at $150.0 million in Q4 2023.
• Average Short term Debt over 4 years is $712.2 million, with a median of $475.0 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2026: Short term Debt jumped 1065.73% in 2024, then jumped 433.33% in 2026.
• Over 4 years, Short term Debt stood at $150.0 million in 2023, then surged by 1065.73% to $1.7 billion in 2024, then tumbled by 91.42% to $150.0 million in 2025, then surged by 433.33% to $800.0 million in 2026.
• The last three Short term Debt figures came in at $800.0 million (Q2 2026), $150.0 million (Q2 2025), and $1.7 billion (Q4 2024), per Business Quant data.